The Microbiome in early life: Self-completion and microbiota protection as health priorities

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 101, Issue 4, 2014, Pages 333-340

  Dietert, Rodney R ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Birth delivery mode; Completed self; Developmental management; Health trajectory; Immune maturation; Microbiome; Microbiota; Noncommunicable diseases; Pregnancy management; Recurrent infections

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; TOXIC SUBSTANCE;

ARTICLE; ENVIRONMENTAL EXPOSURE; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH HAZARD; HUMAN; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MAMMAL; MICROBIOME; MICROFLORA; NEWBORN PERIOD; NON COMMUNICABLE DISEASE; NONHUMAN; PRIORITY JOURNAL; SELF COMPLETION; BIRTH; FEMALE; MICROBIAL CONSORTIUM; PREGNANCY;

MAMMALIA;

FEMALE; HUMANS; MICROBIAL CONSORTIA; MICROBIOTA; PARTURITION; PREBIOTICS; PREGNANCY; PROBIOTICS;

EID: 84905920743     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.21116     Document Type: Article

References (85)

1. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. 2014. The placenta harbors a unique microbiome. Sci Transl Med 6(237):237ra65.
2. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. 2014. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy 44(6):842-850.
3. Al M, Ng L, Tyrrell P, Bargman J, Bradley T, Silverman E. 2009. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. Rheumatology (Oxford) 48(5):497-501.
4. Aldbass AM, Bhat RS, El-Ansary A. 2013. Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. J Neuroinflammation 10(1):42.
5. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. 2010. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 1801(11):1175-1183.
6. Allen-Vercoe E. 2013. Bringing the gut microbiota into focus through microbial culture: recent progress and future perspective. Curr Opin Microbiol 16(5):625-629.
7. An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, Lu X, Zeissig S, Blumberg RS, Kasper DL. 2014. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 156(1-2):123-133.
8. Ardissone AN, de la Cruz DM, Davis-Richardson AG, Rechcigl KT, Li N, Drew JC, Murgas-Torrazza R, Sharma R, Hudak ML, Triplett EW, Neu J. 2014. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One 9(3):e90784.
9. Arimatsu K, Yamada H, Miyazawa H, Minagawa T, Nakajima M, Ryder MI, Gotoh K, Motooka D, Nakamura S, Iida T, Yamazaki K. 2014. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep 4:4828.
10. Barker DJ. 1991. The intrauterine environment and adult cardiovascular disease. Ciba Found Symp 156:3-10.
11. Barker DJ. 2000. In utero programming of cardiovascular disease. Theriogenology 53(2):555-574.
12. Barker DJ, Osmond C, Thornburg KL, Kajantie E, Eriksson JG. 2013. The intrauterine origins of Hodgkin's lymphoma. Cancer Epidemiol 37(3):321-323.
13. Beebe K, Sampey B, Watkins SM, Milburn M, Eckhart AD. 2014. Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. Clin Sci Transl 7(1):74-81.
14. Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell. 157(1):121-141.
15. Berer K., Krishnamoorthy G. 2014. Microbial view of central nervous system autoimmunity. FEBS Lett. pii: S0014-5793(14)00293-2.
16. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. 2010. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 86(Suppl 1):13-15.
17. Cani PD, Everard A, Duparc T. 2013. Gut microbiota, enteroendocrine functions, and metabolism. Curr Opin Pharmacol 13(6):935-940.
18. Cheng J, Kalliomäki M, Heilig HG, Palva A, Lähteenoja H, de Vos WM, Salojärvi J, Satokari R. 2013. Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol 13:113.
19. Choi JJ, Eum SY, Rampersaud E, Daunert S, Abreu MT, Toborek M. 2013. Exercise attenuates PCB-induced changes in the mouse gut microbiome. Environ Health Perspect 121(6):725-730.
20. David AK. 2013. Medical education on a collision course: sooner rather than later? Fam Med 45(3):159-163.
21. denBesten G1, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, Müller M, Groen AK, Hooiveld GJ, Bakker BM, Reijngoud DJ. 2013. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol 305(12):G900-G910.
22. Dietert R, Dietert J. 2012. The completed self: an immunological view of the human-microbiome superorganism and risk of chronic diseases. Entropy 14(11): 2036-2065.
23. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107(26):11971-11975.
24. Douglas-Escobar M, Elliott E, Neu J. 2013. Effect of intestinal microbial ecology on the developing brain. J Am Med Assoc Pediatr 167(4):374-379.
25. Eberl G. 2010. A new vision of immunity: homeostasis of the superorganism. Mucosal Immunol 3(5):450-460.
26. Endesfelder D, Castell WZ, Ardissone A, Davis-Richardson AG, Achenbach P, Hagen M, Pflueger M, Gano KA, Fagen JR, Drew JC, Brown CT, Kolaczkowski B, Atkinson M, Schatz D, Bonifacio E, Triplett EW, Ziegler AG. 2014. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes. 63(6):2006-2014.
27. Foley KA, Ossenkopp KP, Kavaliers M, Macfabe DF. 2014. Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLoS One 9(1):e87072.
28. Funkhouser LJ, Bordenstein SR. 2013. Mom knows best: the universality of maternal microbial transmission. PLoS Biol 11(8):e1001631.
29. Galley JD, Bailey MT. 2014. Impact of stressor exposure on the interplay between commensal microbiota and host inflammation. Gut Microbes 5(3). doi.org/10.4161/gmic.28683
30. Goel A, Gupta M, Aggarwal R. 2014. Gut microbiota and liver disease. J Gastroenterol Hepatol 29(6):1139-1148.
31. González MJ, Gutiérrez AP, Gassió R, Fusté ME, Vilaseca MA, Campistol J. 2011. Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit. Mol Genet Metab 104(Suppl): S73-S79.
32. Greenwood C, Morrow AL, Lagomarcino AJ, Altaye M, Taft DH, Yu Z, Newburg DS, Ward DV, Schibler KR. 2014. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of enterobacter. J Pediatr. pii: S0022-3476(14)00011-0, 165(1):23-29.
33. Hansen CH, Krych L, Buschard K, Metzdorff SB, Nellemann C, Hansen LH, Nielsen DS, Frøkiær H, Skov S, Hansen AK. 2014. A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice. Diabetes. 165(1):23-29.
34. Hing E, Schappert SM. 2012. Generalist and specialty physicians: supply and access, 2009-2010. NCHS Data Brief (105):1-8.
35. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7):1451-1463.
36. Hu J, Nomura Y, Bashir A, Fernandez-Hernandez H, Itzkowitz S, Pei Z, Stone J, Loudon H, Peter I. 2013. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One 8(11):e78257.
37. Hu J, Kong M, Ye Y, Hong S, Cheng L, Jiang L. 2014. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy. J Neurochem. 129(5):877-883.
38. Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, Björkstén B, Engstrand L, Andersson AF. 2014. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 63(4):559-566.
39. Joly C, Gay-Quéheillard J, Léké A, Chardon K, Delanaud S, Bach V, Khorsi-Cauet H. 2013. Impact of chronic exposure to low doses of chlorpyrifos on the intestinal microbiota in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in the rat. Environ Sci Pollut Res Int 20(5):2726-2734.
40. Jost T, Lacroix C, Braegger C, Chassard C. 2014. Stability of the maternal gut microbiota during late pregnancy and early lactation. Curr Microbiol 68(4):419-427.
41. Kamada N, Núñez G. 2013. Role of the gut microbiota in the development and function of lymphoid cells. J Immunol 190(4):1389-1395.
42. Kang MJ, Kim HG, Kim JS, Oh do G, Um YJ, Seo CS, Han JW, Cho HJ, Kim GH, Jeong TC, Jeong HG. 2013. The effect of gut microbiota on drug metabolism. Expert Opin Drug Metab Toxicol 9(10):1295-1308.
43. Kish L, Hotte N, Kaplan GG, Vincent R, Tso R, Gänzle M, Rioux KP, Thiesen A, Barkema HW, Wine E, Madsen KL. 2013. Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One 8(4):e62220.
44. Klünemann M, Schmid M, Patil KR. 2014. Computational tools for modeling xenometabolism of the human gut microbiota. Trends Biotechnol 32(3):157-165.
45. Korpela K, Flint HJ, Johnstone AM, Lappi J, Poutanen K, Dewulf E, Delzenne N, de Vos WM, Salonen A. 2014. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One 9(3):e90702.
46. Li H, Jia W. 2013. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther 94(5):574-581.
47. Li M, Wang M, Donovan SM. 2014. Early development of the gut microbiome and immune-mediated childhood disorders. Semin Reprod Med 32(1):74-86.
48. Lin XB, Farhangfar A, Valcheva R, Sawyer MB, Dieleman L, Schieber A, Gänzle MG, Baracos V. 2014. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS One 9(1):e83644.
49. Liu Y, Li Y, Liu K, Shen J. 2014. Exposing to cadmium stress cause profound toxic effect on microbiota of the mice intestinal tract. PLoS One 9(2):e85323.
50. Lu K, Abo RP, Schlieper KA, Graffam ME, Levine S, Wishnok JS, Swenberg JA, Tannenbaum SR, Fox JG. 2014. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect 122(3):284-291.
51. Ma J, Prince A, Aagaard KM. 2014. Use of whole genome shotgun metagenomics: a practical guide for the microbiome-minded physician scientist. Semin Reprod Med 32(1):5-13
52. MacFabe D. 2013. Autism: metabolism, mitochondria, and the microbiome. Glob Adv Health Med 2(6):52-66.
53. MacFabe DF. 2012. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. doi:10.3402/mehd.v23i0.19260
54. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP. 2007. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176(1):149-169.
55. Madan JC, Salari RC, Saxena D, Davidson L, O'Toole GA, Moore JH, Sogin ML, Foster JA, Edwards WH, Palumbo P, Hibberd PL. 2012. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 97(6):F456-F462.
56. Makino H, Kushiro A, Ishikawa E, Kubota H, Gawad A, Sakai T, Oishi K, Martin R, Ben-Amor K, Knol J, Tanaka R. 2013. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One 8(11):e78331.
57. Matuskova Z, Anzenbacherova E, Vecera R, Tlaskalova-Hogenova H, Kolar M, Anzenbacher P. 2014. Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. PLoS One 9(2):e87150.
58. Mejía-León ME, Petrosino JF, Ajami NJ, Domínguez-Bello MG, de la Barca AM. 2014. Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci Rep 4:3814.
59. Montiel-Castro AJ, González-Cervantes RM, Bravo-Ruiseco G, Pacheco-López G. 2013. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci 7:70.
60. Murdoch TB, Detsky AS. 2012. Time to recognize our fellow travellers. J Gen Intern Med 27(12):1704-1706.
61. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. 2014. Role of the microbiome in energy regulation and metabolism. Gastroenterology 146(6):1525-3153.
62. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, Blumberg RS. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336(6080):489-493.
63. Power SE, O'Toole PW, Stanton C, Ross RP, Fitzgerald GF. 2014. Intestinal microbiota, diet and health. Br J Nutr 111(3):387-402.
64. Prince AL, Antony KM, Ma J, Aagaard KM. 2014. The microbiome and development: a mother's perspective. Semin Reprod Med 32(1):14-22.
65. Raipal DK, Brown JR. 2013. Modulating the human gut microbiome as the emerging therapeutic paradigm. Sci Prog 96:224-236.
66. Ramezani A1, Raj DS. 2014. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 25(4):657-670.
67. Remely M, Aumueller E, Merold C, Dworzak S, Hippe B, Zanner J, Pointner A, Brath H, Haslberger AG. 2014. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537(1):85-92.
68. Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, Galuppi M, Lamont RF, Chaemsaithong P, Miranda J, Chaiworapongsa T, Ravel J. 2014. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2(1):4.
69. Rousseau C, Levenez F, Fouqueray C, Doré J, Collignon A, Lepage P. 2011. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol 49(3):858-865.
70. Shehata AA, Schrödl W, Aldin AA, Hafez HM, Krüger M. 2013. The effect of glyphosate on potential pathogens and beneficial members of poultry microbiota in vitro. Curr Microbiol 66(4):350-358.
71. Sleator RD. 2010. The human superorganism-of microbes and men. Med Hypotheses 74(2):214-215.
72. Snedeker SM, Hay AG. 2012. Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect 120(3):332-339.
73. Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. 2014. Differences in the gut microbiota in healthy children and those with type 1 diabetes. Pediatr Int. 56(13):336-343
74. Stencel-Gabriel K, Gabriel I, Wiczkowski A, Paul M, Olejek A. 2009. Prenatal priming of cord blood T lymphocytes by microbiota in the maternal vagina. Am J Reprod Immunol 61(3):246-252.
75. Sun L, Sun S, Li Y, Pan W, Xie Y, Wang S, Zhang Z. 2014. Potential biomarkers predicting risk of pulmonary hypertension in congenital heart disease: the role of homocysteine and hydrogen sulfide. Chin Med J 127(5):819-899.
76. Sylvester KG, Ling XB, Liu GY, Kastenberg ZJ, Ji J, Hu Z, Peng S, Lau K, Abdullah F, Brandt ML, Ehrenkranz RA, Harris MC, Lee TC, Simpson J, Bowers C, Moss RL. 2013. A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut. doi:10.1136/gutjnl-2013-305130
77. Taneja V. 2014. Arthritis susceptibility and the Gut Microbiome. FEBS Lett. pii: S0014-5793(14)00421-9.
78. Tang Y, Chen Y, Jiang H, Nie D. 2011. Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death. Cell Death Differ 18(4):602-618.
79. Tilg H, Moschen AR. 2014. Microbiota and diabetes: an evolving relationship. Gut. pii: gutjnl-2014-306928. doi:10.1136/gutjnl-2014-306928.
80. Tuohy KM, Fava F, Viola R. 2014. 'The way to a man's heart is through his gut microbiota'-dietary pro- and prebiotics for the management of cardiovascular risk. Proc Nutr Soc 73(2):172-185.
81. Wallace BD, Redinbo MR. 2013. The human microbiome is a source of therapeutic drug targets. Cuur Opin Chem Biol 17(3):379-384.
82. Walthall K, Cappon GD, Hurtt ME, Zoetis T. 2005. Postnatal development of the gastrointestinal system: a species comparison. Birth Defects Res B Dev Reprod Toxicol 74(2):132-156.
83. Yu ZT, Chen C, Newburg DS. 2013. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology 23(11):1281-1292.
84. Zhang X, Qi X, Yang Z, Serey B, Sovannary T, Bunnath L, Seang Aun H, Samnom H, Zhang H, Lin Q, van Oven M, Shi H, Su B. 2013. Analysis of mitochondrial genome diversity identifies new and ancient maternal lineages in Cambodian aborigines. Nat Commun 4:2599.
85. Zhu Q, Gao R, Wu W, Qin H. 2013. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol 34(3):1285-1300.